229 related articles for article (PubMed ID: 27061971)
1. Dropout rates in exposure with response prevention for obsessive-compulsive disorder: What do the data really say?
Ong CW; Clyde JW; Bluett EJ; Levin ME; Twohig MP
J Anxiety Disord; 2016 May; 40():8-17. PubMed ID: 27061971
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder.
Johnco C; McGuire JF; Roper T; Storch EA
Depress Anxiety; 2020 May; 37(5):407-417. PubMed ID: 31778595
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of cognitive-behavioral therapy for obsessive-compulsive disorder.
McKay D; Sookman D; Neziroglu F; Wilhelm S; Stein DJ; Kyrios M; Matthews K; Veale D;
Psychiatry Res; 2015 May; 227(1):104-13. PubMed ID: 25937054
[TBL] [Abstract][Full Text] [Related]
4. Patient adherence to cognitive behavioural therapy for obsessive-compulsive disorder: A systematic review and meta-analysis.
Leeuwerik T; Cavanagh K; Strauss C
J Anxiety Disord; 2019 Dec; 68():102135. PubMed ID: 31704633
[TBL] [Abstract][Full Text] [Related]
5. Adding acceptance and commitment therapy to exposure and response prevention for obsessive-compulsive disorder: A randomized controlled trial.
Twohig MP; Abramowitz JS; Smith BM; Fabricant LE; Jacoby RJ; Morrison KL; Bluett EJ; Reuman L; Blakey SM; Ledermann T
Behav Res Ther; 2018 Sep; 108():1-9. PubMed ID: 29966992
[TBL] [Abstract][Full Text] [Related]
6. Group cognitive behavioural therapy for obsessive-compulsive disorder: a systematic review and meta-analysis.
Jónsson H; Hougaard E
Acta Psychiatr Scand; 2009 Feb; 119(2):98-106. PubMed ID: 18822090
[TBL] [Abstract][Full Text] [Related]
7. Potentials and limitations of cognitive treatments for obsessive-compulsive disorder.
Abramowitz JS; Taylor S; McKay D
Cogn Behav Ther; 2005; 34(3):140-7. PubMed ID: 16195053
[TBL] [Abstract][Full Text] [Related]
8. Personalized exposure and experience sampling method feedback versus exposure as usual for obsessive-compulsive disorder: a study protocol for a randomized controlled trial.
Hoogerwerf E; Greeven A; Goekoop R; Spinhoven P
Trials; 2024 Jan; 25(1):43. PubMed ID: 38217045
[TBL] [Abstract][Full Text] [Related]
9. Group and individual treatment of obsessive-compulsive disorder using cognitive therapy and exposure plus response prevention: a 2-year follow-up of two randomized trials.
Whittal ML; Robichaud M; Thordarson DS; McLean PD
J Consult Clin Psychol; 2008 Dec; 76(6):1003-14. PubMed ID: 19045968
[TBL] [Abstract][Full Text] [Related]
10. Treatment of obsessive-compulsive disorder: cognitive behavior therapy vs. exposure and response prevention.
Whittal ML; Thordarson DS; McLean PD
Behav Res Ther; 2005 Dec; 43(12):1559-76. PubMed ID: 15913543
[TBL] [Abstract][Full Text] [Related]
11. Does the addition of cognitive therapy to exposure and response prevention for obsessive compulsive disorder enhance clinical efficacy? A randomized controlled trial in a community setting.
Rector NA; Richter MA; Katz D; Leybman M
Br J Clin Psychol; 2019 Mar; 58(1):1-18. PubMed ID: 29984550
[TBL] [Abstract][Full Text] [Related]
12. Online Video Teletherapy Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention: Clinical Outcomes From a Retrospective Longitudinal Observational Study.
Feusner JD; Farrell NR; Kreyling J; McGrath PB; Rhode A; Faneuff T; Lonsway S; Mohideen R; Jurich JE; Trusky L; Smith SM
J Med Internet Res; 2022 May; 24(5):e36431. PubMed ID: 35587365
[TBL] [Abstract][Full Text] [Related]
13. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
van Oppen P; van Balkom AJ; Smit JH; Schuurmans J; van Dyck R; Emmelkamp PM
J Clin Psychiatry; 2010 Sep; 71(9):1158-67. PubMed ID: 20361906
[TBL] [Abstract][Full Text] [Related]
14. The psychological treatment of obsessive-compulsive disorder.
Abramowitz JS
Can J Psychiatry; 2006 Jun; 51(7):407-16. PubMed ID: 16838822
[TBL] [Abstract][Full Text] [Related]
15. D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.
Xia J; Du Y; Han J; Liu G; Wang X
Drug Des Devel Ther; 2015; 9():2101-17. PubMed ID: 25960632
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of cognitive-behavioral therapy for obsessive-compulsive disorder.
McKay D; Sookman D; Neziroglu F; Wilhelm S; Stein DJ; Kyrios M; Matthews K; Veale D
Psychiatry Res; 2015 Feb; 225(3):236-46. PubMed ID: 25613661
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials.
Tolin DF; Hannan S; Maltby N; Diefenbach GJ; Worhunsky P; Brady RE
Behav Ther; 2007 Jun; 38(2):179-91. PubMed ID: 17499084
[TBL] [Abstract][Full Text] [Related]
18. Drop-out and efficacy of group versus individual cognitive behavioural therapy: What works best for Obsessive-Compulsive Disorder? A systematic review and meta-analysis of direct comparisons.
Pozza A; Dèttore D
Psychiatry Res; 2017 Dec; 258():24-36. PubMed ID: 28982038
[TBL] [Abstract][Full Text] [Related]
19. No talking, just writing! Efficacy of an Internet-based cognitive behavioral therapy with exposure and response prevention in obsessive compulsive disorder.
Herbst N; Voderholzer U; Thiel N; Schaub R; Knaevelsrud C; Stracke S; Hertenstein E; Nissen C; Külz AK
Psychother Psychosom; 2014; 83(3):165-75. PubMed ID: 24732962
[TBL] [Abstract][Full Text] [Related]
20. How willing are you? Willingness as a predictor of change during treatment of adults with obsessive-compulsive disorder.
Reid AM; Garner LE; Van Kirk N; Gironda C; Krompinger JW; Brennan BP; Mathes BM; Monaghan SC; Tifft ED; André MC; Cattie J; Crosby JM; Elias JA
Depress Anxiety; 2017 Nov; 34(11):1057-1064. PubMed ID: 28715850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
